Retraction notice to 'Results from a 12 months, randomized, clinical trial comparing an olmesartan/amlodipine single pill combination to olmesartan and amlodipine monotherapies on blood pressure and inflammatin' [European Journal of Pharmaceutical Sciences 51C (2013) 26-33]

Autor:	Anna Carbone, Angela D'Angelo, Giuseppe Derosa, Arrigo F G Cicero, Fabrizio Querci, Pamela Maffioli, Elena Fogari
Rok vydání:	2018
Předmět:	medicine.medical_specialty Single pill combination Notice business.industry Pharmaceutical Science law.invention Blood pressure Randomized controlled trial law Internal medicine medicine Amlodipine Pharmaceutical sciences business Olmesartan medicine.drug
Zdroj:	European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences. 123
ISSN:	1879-0720
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3d856240e7f470b4abbf89508e799a0c https://pubmed.ncbi.nlm.nih.gov/23999037 Zobrazit plný text záznamu Full Text from ScienceDirect